Download PDF

Other users also viewed these articles

Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study J.M. Mostaza; C. Lahoz; M.G. de Yébenes Castro; J.M. Rubio Campal; E. Velásquez; A. Ibarra Gutiérrez; J.F. Díaz; N. Plana; M. Rodríguez-Mañero; J. de Dios García-Díaz; F. Martínez Debén; I. Pavón de Paz; A.L. Catapano; G. Díaz Moya; K.K. Ray;
Rev Clin Esp. 2025;225:
Clinical characteristics of premature cardiovascular disease in our health area M. Viscasillas; I. Lamíquiz-Moneo; M.R. Pérez-Ruiz; R. Garcia-Fenoll; E. Jarauta;
Rev Clin Esp. 2022;222:348-53
Consensus document for lipid profile testing and reporting in Spanish clinical laboratories Teresa Arrobas Velilla; Carlos Guijarro; Raquel Campuzano Ruiz; Manuel Rodríguez Piñero; José Francisco Valderrama Marcos; Antonio Pérez Pérez; Manuel Antonio Botana López; Ana Morais López; José Antonio García Donaire; Juan Carlos Obaya; Luis Castilla Guerra; Vicente Pallares Carratalá; Isabel Egocheaga Cabello; Mercedes Salgueira Lazo; María Mar Castellanos Rodrigo; José María Mostaza Prieto; Juan José Gómez Doblas; Antonio Buño Soto;
Rev Clin Esp. 2023;223:440-9